Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/a0/f3/11/a0f311c5-1115-ecc0-693c-f2cdade4c288/mza_7150422634596950293.jpg/600x600bb.jpg
Cannabis in 10
8th Revolution
147 episodes
1 week ago
Learn about the exploding cannabis industry from the ones building it in less than 10 minutes. This is Cannabis in 10..
Show more...
Alternative Health
Business,
Management,
Entrepreneurship,
Health & Fitness
RSS
All content for Cannabis in 10 is the property of 8th Revolution and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Learn about the exploding cannabis industry from the ones building it in less than 10 minutes. This is Cannabis in 10..
Show more...
Alternative Health
Business,
Management,
Entrepreneurship,
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/a0/f3/11/a0f311c5-1115-ecc0-693c-f2cdade4c288/mza_7150422634596950293.jpg/600x600bb.jpg
Curaleaf's European Breakout & Boris Jordan Strategy for The Hemp Company
Cannabis in 10
10 minutes 57 seconds
1 year ago
Curaleaf's European Breakout & Boris Jordan Strategy for The Hemp Company
The lack of guidance from the US Federal Government on the cannabinoid industry poses significant challenges for those involved in the sector. The absence of clear regulations and leadership complicates business operations. In contrast, European countries are both legalizing cannabis and planning further legalization. They are keen to avoid the mistakes made by many US states and are learning from past failures. This week, we sit down with Boris Jordan to discuss How the NGC acquisition will drive Curaleaf's growth in Europe & Why Curaleafs in the Hemp Market FruitStiq, Hemp Beverages, and so much more About Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. #CURA #BorisJordan #Curaleaf Follow us: Our Links. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. 8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here: 🎥 YouTube: The Dime 📸 Instagram: The Dime
Cannabis in 10
Learn about the exploding cannabis industry from the ones building it in less than 10 minutes. This is Cannabis in 10..